Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

BMB. 2018; 3(2): 26-29


Relationship between percutaneous tracheostomy timing with APACHE II and SOFA scores in critically ill patients’ the first day of ICU

KEREM ERKALP, DOĞAN KILIÇ, FUNDA GÜMÜŞ ÖZCAN, MEHMET SALİH SEVDİ, MELİKE ÇAĞATAY, SERDAR DEMİRGAN, AYŞİN SELCAN.




Abstract

AIM/BACKGROUND: Our study aimed to assess the relevance between critical ill patients’ the first day of acceptance APACHE II and SOFA scoring scales with the timing of percutaneous dilatational tracheotomy (PDT).
METHODs: Following approval of the Ethical Board of Health Sciences University Istanbul Bağcılar Educational Research Hospital (25.08.2016-2016/495), data of all 91 patients who have been treated with PDT between 01.06.2014–01.06.2016 in ICU, have been retrospectively evaluated. We have saved the following: demographical data (such as age, sex, body mass index) which can be reached from patient records, APACHE II and SOFA scores from their first day in ICU, and had PDT timing.
RESULTS: There was no statistically significant difference observed between the timing of the PDT and APACHE II and SOFA scoring scales (p>0.05).
CONCLUSION: Our results showed that most of the patients with PDT has 15-24 levels of APACHE II score. We have recognized that number of patients with 24 and higher APACHE II score is notably lower than number of patients with scores between 15-24. The fact that the life expectancy from the patient group who holds high APACHE II score is low, may make the tracheostomy decision questionable. On the other hand, there had been no relevance recognized between differences between APACHE II scores and the opening timing of PDT.

Key words: Tracheostomy, mortality score, timing, critical care, APACHE






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.